News
The article is more than 12 years old

Finnish pharma to treat cocaine-dependent US veterans?

Finnish pharma company Biotie Therapies is launching a drug trial in the US investigating the treatment of cocaine dependence. The multi-million dollar study is funded by the US Department of Defence, which is looking to remedy drug dependence among its veterans returning from Iraq and Afghanistan.

Research at Biotie Therapies: close-up image of the test tubes. (Biotien tutkimuspulloja)
Image: YLE

Finnish researchers are hoping nepicastat, a dopamine inhibitor, will be a magic bullet for treating both cocaine dependence and post-traumatic stress disorder (PTSD).

“Among returning veterans, the drug problem is even worse than during the Vietnam war,” says Biotie chief executive Timo Veromaa.

Nepicastat, a synthetic drug administered as an oral tablet, is being tested at a dozen substance abuse treatment centres across the United States.

“PTSD is very difficult to treat and psychotherapy doesn’t always help,” says Veromaa.

It can take years for a new drug to come through the pipeline. That said, it could be years before nepicastat reaches pharmacy shelves.

Sources: YLE